Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden.
BACKGROUND: Risk models to predict prostate cancer on biopsy, whether they include only prostate-specific antigen (PSA) or other markers, are intended for use in all men of screening age. However, the association between PSA and cancer probably depends on a man's recent screening history. METHO...
Hlavní autoři: | Vickers, A, Cronin, A, Aus, G, Pihl, C, Becker, C, Pettersson, K, Scardino, P, Hugosson, J, Lilja, H |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2010
|
Podobné jednotky
-
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Goteborg, Sweden.
Autor: Vickers, A, a další
Vydáno: (2008) -
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
Autor: Scardino Peter T, a další
Vydáno: (2008-07-01) -
Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening.
Autor: Zackrisson, B, a další
Vydáno: (2003) -
Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden.
Autor: Hugosson, J, a další
Vydáno: (2003) -
Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy.
Autor: Vickers, A, a další
Vydáno: (2010)